globenewswire.com · Nov 12, 2025
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
- Former Chimerix (CMRX, acquired by Jazz for $935 million) Senior Commercial Leader Michael Grabow led Go-To-Market Strategy and Launch for rare disease therapeutic MODEYSO® -

